BROLUCIZUMAB (BeovuĀ®)

Clinical Indication

Wet ARMD

Comments

In line with NICE TA672

Date of classification

June 2020

Review date

March 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).